Ionis Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1994
Net Income	-384.77	-366.29	-269.72	-28.6	-444.26	278.14	Upgrade
Depreciation & Amortization	22.54	22.5	22.11	19.56	17.16	14.08	Upgrade
Share-Based Compensation	110.2	105.81	100.26	120.68	230.12	146.57	Upgrade
Other Operating Activities	-71.44	-69.53	-127.02	-80.84	232.88	-93.17	Upgrade
Operating Cash Flow	-323.46	-307.51	-274.37	30.8	35.89	345.63	Upgrade
Operating Cash Flow Growth	-	-	-	-14.19%	-89.62%	-42.67%	Upgrade
Capital Expenditures	-17.8	-23.78	238.36	-11.96	-35.12	-30.91	Upgrade
Change in Investments	209.61	-186.14	-496.62	212.81	315.53	-4.99	Upgrade
Other Investing Activities	-4.19	-4.21	-4.38	-5.95	-5.93	-5.38	Upgrade
Investing Cash Flow	187.62	-214.13	-262.64	194.91	274.48	-41.27	Upgrade
Share Issuance / Repurchase	70.49	49.44	6.37	101.32	-38.51	141.38	Upgrade
Debt Issued / Paid	72.72	562.29	-50.72	297.96	0	86.57	Upgrade
Other Financing Activities	32.35	32.35	-10.95	-153.35	-558.1	-127.93	Upgrade
Financing Cash Flow	175.57	644.08	-55.3	245.93	-596.61	100.02	Upgrade
Exchange Rate Effect	0.13	0.35	-0.42	-0.11	0.62	0.09	Upgrade
Net Cash Flow	39.86	122.79	-592.72	471.53	-285.62	404.47	Upgrade
Free Cash Flow	-341.26	-331.3	-36.01	18.84	0.77	314.72	Upgrade
Free Cash Flow Growth	-	-	-	2340.93%	-99.75%	-46.59%	Upgrade
Free Cash Flow Margin	-43.94%	-42.06%	-6.13%	2.33%	0.11%	28.04%	Upgrade
Free Cash Flow Per Share	-2.35	-2.31	-0.25	0.13	0.01	2.25	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).